The Lung Nodule Program is aimed at optimizing care for patients with
incidentally discovered focal pulmonary lesions. As use of sophisticated
computed tomography (CT) has increased, incidental detection of small
lung nodules has become routine. While most pulmonary nodules prove to
be benign, it is important to follow these nodules carefully, as some do
represent early carcinoma.
This program provides a formal mechanism for lung nodule management and
begins with a specialist review of a newly discovered incidental lung
nodule and determination of appropriate follow-up recommendations based
on national guidelines and specialist expertise.
Lung Nodule Program protocol includes:
Lung nodule assessment within one week of referral by the Lung
Nodule Program's team of specialists in pulmonary medicine
A prompt report—within 24 hours (one business day)—of the team's
assessment and follow-up recommendations; the report will be
guided by the Fleischner Society recommendations and may
No further evaluation or follow up
Serial CT surveillance to assess and track the
nodule(s), watching for changes that signal a
need to investigate further
Diagnostic investigation and/or biopsy
Tracking and proactive outreach by the Program's dedicated nurse
navigator for management of follow-up care, including
appointment reminders to ensure and document compliance with any
continuing surveillance recommendations
Incidentally discovered lung nodules may cause considerable patient
anxiety and may be challenging for physicians to manage. This program
will help optimize management of your patients with newly discovered
For further information about the Lung Nodule Program at Lankenau or to
refer a patient for program participation, please contact the program's
nurse navigator, Rosemarie Tucci, RN, MSN, at 484.565.LUNG.
For more information, call 1.866.CALL.MLH.